Based in Anaheim, California, Manny Bojorquez is an entrepreneur involved with multiple ventures. As the owner of peaCURE, Manny Bojorquez has been a part of a larger trend of addressing pain management.
More recently, researchers have discovered the efficacy of PEA in reducing inflammation. Formally known as palmitoylethanolamide, PEA is a cannabimimetic that occurs naturally in the body.
When inflammation occurs in the body, a series of processes trigger the production of lipid (protein) mediators that shut down inflammation. PEA is one of these mediators.
PEA is an effective mediator in reducing inflammation and pain, and this fact has been substantiated through pre-clinical studies. The protein has been proven to have both anti-inflammatory and anti-analgesic effects and reduces pain. These findings are important in the scope of being an alternative to treating pain. Currently, opioids are the primary methods used to treat pain, a therapy that comes with an amalgam of side effects including addiction.
However, some experts suggest that PEA can replace traditional forms of opioid treatment. In the case of the above article in Pain Therapy, researchers found PEA could be used concomitantly with opioids to relieve pain and reduce the degree that patients have to rely on the latter.
